Acute Porphyria Drug Database

Monograph

M05BA01 - Etidronic Acid
Not porphyrinogenic
NP

Rationale
Inorganic compound. Accumulates in bone tissue. Not metabolised. Two references use with care/authorised.
Chemical description
Bisphosphonate which is an analogue to naturally occuring pyrophosphate. Absorbed to bone it counteracts osteoporosis. South African list: use with care. French list: authorized.
IPNet drug reports
Uneventful use reported in 1 patient with acute porphyria.

Similar drugs
Explore alternative drugs in similar therapeutic classes M05B / M05BA or go back.

Tradenames and packages
From some sources, we get a list of packages (United Kingdom, Ireland, Estonia). Other sources contain more or less "clean" versions of the trade name (Denmark, Finland, Iceland, Lithuania, Norway). What you see here is the raw data we get from each country, so there will appear to be duplicates. The bold names are the searchable terms. The gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors. We strive to improve it continuously.
United Kingdom
Didronel · Didronel 200mg tablets · Didronel 400mg tablets · Etidronate disodium · Etidronate disodium 100mg/5ml oral suspension · Etidronate disodium 200mg tablets · Etidronate disodium 400mg/5ml oral suspension
 
© NAPOS 2024
An unhandled error has occurred. Reload 🗙